Compare NVEC & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVEC | MDCX |
|---|---|---|
| Founded | 1989 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.9M | 53.4M |
| IPO Year | 1996 | N/A |
| Metric | NVEC | MDCX |
|---|---|---|
| Price | $68.09 | $1.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.50 |
| AVG Volume (30 Days) | 49.8K | ★ 346.6K |
| Earning Date | 01-21-2026 | 11-14-2025 |
| Dividend Yield | ★ 5.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.85 | N/A |
| Revenue | ★ $24,784,396.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $24.97 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $51.50 | $1.60 |
| 52 Week High | $88.50 | $8.94 |
| Indicator | NVEC | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 48.11 | 37.41 |
| Support Level | $70.12 | $1.68 |
| Resistance Level | $73.42 | $2.03 |
| Average True Range (ATR) | 2.49 | 0.20 |
| MACD | 0.22 | -0.02 |
| Stochastic Oscillator | 38.67 | 14.93 |
NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.